Empowering leaders in regulated scientific sectors to engage with impact | Launching an app for HCPs to track and grow their impact online: HCPeers.app
Joined April 2009
- Tweets 6,063
- Following 3,108
- Followers 3,576
- Likes 1,640
276 Photos and videos
Apr 29
Research shows the most peer-trusted healthcare professional voices shaping NSCLC scientific learning online during the last three years of ASCO.
@CREATION's unique HCP Peer Impact metric, an algorithm based on how often other HCPs mention a particular HCP within a specific conversation (in this case, posts about lung cancer during ASCO medical congress), is a powerful way to identify which oncologists or other HCPs are most trusted by their online peers.
You'll notice that the most peer-trusted HCPs are not necessarily the noisiest or most-prolific posters, but they certainly play their part.
Ones to watch for #ASCO26:
#1 @StephenVLiu
#2 @HHorinouchi
#3 @CharuAggarwalMD
#4 @RManochakian
#5 @DrJNaidoo
#ASCO23 #ASCO24 #ASCO25 #ASCO26
2
3
654
4 Dec 2025
Do not be misled: #Deepfakes and #misinformation are a threat to patient safety.
Yes, you heard that correctly: deepfaking Digital Opinion Leaders is a real thing, and a real threat.
As we head towards #SABCS25 #SABCS2025, here's our trailer for my incredible conversation with the inspiring @drteplinsky - breast cancer advocate and Digital Opinion Leader.
Coming soon on the Better Listening for Better Health podcast creation.co/podcast
...it's been a long time coming but I'm so glad to start releasing my latest conversations with the HCPs and scientists shaping healthcare!
2
2
293
4 Sep 2025
"Editors and publishers cannot fall back upon the convenient theory of irresponsibility as to advertisements [containing medical misinformation]... They are parties in the transaction and share the profits of this deception practised upon the ignorance and credulousness of the masses they profess to educate and protect."
Boston Medical and Surgical Journal, 1866
The @RoySocMed library is a nice spot in Central London to get some work done in between meetings. I could spend days here - today I enjoyed browsing a few ancient medical journals, with articles from more than 150 years ago describing the latest medical science in the 1800s.
One thing that struck me: doctors tackling medical misinformation in popular media is nothing new!
Here's to all the healthcare professionals today who work tirelessly to combat misinformation on social media.
1
4
236
4 Sep 2025
"Editors and publishers cannot fall back upon the convenient theory of irresponsibility as to advertisements [containing medical misinformation]... They are parties in the transaction and share the profits of this deception practised upon the ignorance and credulousness of the masses they profess to educate and protect."
Boston Medical and Surgical Journal, 1866
73
Publications such as these were significantly amplified by HCPs at #ESCCongress.
HCPs like @DrPascalMeier and @Drroxmehran who referenced the #AQUATIC @NEJM publication also interpreted the data in real-time, helping peers stay informed of the latest data and recommendations.
1
1
158
We tracked the most-shared journals by HCPs online on day 3 of #ESCCongress.
The #AQUATIC publication in @NEJM drove HCP discussions discouraging the use of aspirin in patients with chronic coronary syndrome who were already receiving oral anticoagulation.
🧵 1/3
1
1
2
306
31 Aug 2025
Here's the TL;DR:
@Bayer @Merck's VICTOR trial was most-discussed by HCPs at #ESCCongress on Saturday, despite not meeting primary endpoint.
#2: BMBF's DIGIT-HF
#3: @TIMIStudyGroup's DAPA-ACT HF-TIMI 68 (with @AstraZeneca)
#4: @Bayer @Merck's VICTORIA
#5 @Rigshospitalet's POTCAST
#6: Pr Eva Prescott's BETAMI–DANBLOCK
#7: @BMSNews' ODYSSEY-HCM
#8: @AstraZeneca's BaxHTN
#9: @Pfizer @TorBiering's DAN-RSV
#10: @Cytokinetics' MAPLE-HCM
Day 2 of #ESCCongress flew by!
We tracked the most mentioned trials discussed by HCPs online on day 2 of ESC. The VICTOR trial, sponsored by @Merck, generated the most conversation despite not meeting its primary end-point.
🧵1/3
3
2
654
Got your coffee? Pick up a waffle at @CREATION #ESCCongress stand E555 when you complete a quick challenge!
#ESCWaffles
2
2
142
31 Aug 2025
ICYMI here's @CREATION's quick summary of the trials most-discussed by HCPs online at #ESCCongress on day 2 (Saturday).
@CREATION's analysis cuts out the noise, and distils only the HCP voice on #socialmedia.
Read the thread for more info...
Day 2 of #ESCCongress flew by!
We tracked the most mentioned trials discussed by HCPs online on day 2 of ESC. The VICTOR trial, sponsored by @Merck, generated the most conversation despite not meeting its primary end-point.
🧵1/3
1
153
30 Aug 2025
We ranked >11,000 HCPs who talk about #HeartFailure on X.
See where you rank, at #ESCCongress stand E555 with @CREATION.
Currently the world's most peer-impactful HCPs in HF?
#1 @AndrewJSauer
#2 @HanCardioMD
#3 @gcfmd
#4 @mvaduganathan
#5 @GiuseppeGalati_
1
5
15
2,104
30 Aug 2025
...closely followed by:
#6 @hvanspall
#7 @DrMarthaGulati
#8 @SeguraCardio
#9 @DrRajivsankar
#10 @iamritu
Where do you rank among the 11,000? Come find out at #ESCCongress @CREATION stand E555 (Hall8)
2
7
219
We tracked the most-mentioned cardiology indications discussed by online HCPs on #ESCCongress day 1, and #HeartFailure came out on top.
Big peer impact from @HanCardiomd and @KardiologieHH drove high HCP engagement
Read more: linkedin.com/feed/update/urn…
🧵 1/4
1
3
4
349
29 Aug 2025
The #ESCCongress Twitter [X] feed is alive today! A rush of new #cardiology science is being shared around the world by many of the world's leading HCPs in the field.
...like this:
29 Aug 2025
🚨 Breaking News from #ESCCongress:
The 2025 ESC/EACTS Guidelines on Valvular Heart Disease are out!
Key updates:
🫀 Heart Teams & advanced imaging central to diagnosis & treatment
🫀 #TAVI extended to ≥70y anatomically suitable tricuspid AS pts, regardless of surgical risk
🫀 New Class IIa: early intervention in asymptomatic severe high-gradient AS
🫀 New Class I: early surgical repair for asymptomatic severe primary MR
🫀 TEER upgraded:
✔ Class IIa for high-risk primary MR
✔ Class I for HF severe secondary MR with LVEF <50%
🫀 Stronger role for tricuspid surgery & emerging TTVI for high-risk pts
🫀 Updated antithrombotic & valve dysfunction recommendations
🫀 New sections: cancer VHD, acute HF, multiple/mixed VHD, and sex-specific management
📖 Full text in @ESC_Journals:
👉 🔗academic.oup.com/eurheartj/a…
#VHD #CardioX #ESC2025 #EACTS
1
97
29 Aug 2025
Science at #ESC2025 is not only happening on the ground in Madrid, but all over the world, thanks to HCPs on social media!
But which HCPs should you listen to during #ESC2025 #ESCCongress? You could start with the #ESCCongress Social Media Ambassadors:
HCPs - to track and grow your own impact on your peers online, get the new app launching in public beta ESC today, HCPeers - come see us on stand E555 (between @EliLillyandCo, @AstraZeneca and @novonordisk) or visit HCPeers.app
Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease:
Marcin Kurzyna, MD, PhD, FESC @marcin_kurzyna
Jolanda Sabatino @JSabatino86
Maggie Simpson @m4ggiesimpson
Novi Yanti Sari @slumberbell
Mariana Brandão @MSBBrandao
Julia Grapsa @JGrapsa
Pablo Perez Lopez @pabloplopez_
Preventative Cardiology:
Buket Akinci @PTBuketAkinci
Silvia Castelletti @SilCastelleiit
Svetlana Mosteoru @SMosteoru
Özcan Başaran @ozcan__basaran
Interventional Cardiology & CV Surgery:
Erik Rafflenbeul @KardiologieHH
Mirvat Alasnag @mirvatalasnag
Giulia Masiero @giuliamasiero3
Dr. med. Obayda Azizy, FESC, FACVC @O_Azizy_MD
Imaging:
Pablo Perez Lopez @pabloplopez_
Cornelia Margineanu @corneliacrm
Mariana Brandao @MSBBrandao
Julia Graspa @JGrapsa
Yousef Daryani @ydaryani
Hypertension:
Anastasia Mihailidou @AnastasiaSMihai
Rosa Maria Bruno @rosam_bruno
1
2
5
387
29 Aug 2025
...and in Heart Failure:
Jan Biegus @JanBiegus
Priv.-Doz. Dr. Amr Abdin @AmrAbdin10
Oren Caspi @MDCaspi
Novi Yanto Sari @slumberbell
Jozine ter Maaten @jozinetm
Cornelia Margineanu @corneliacrm
Nan Naung Tun @HanCardiomd (the world's #2 most peer-impactful HCP in the Heart Failure conversation, according to DOL Finder - being demonstrated at the @CREATION stand E555)
CV Pharmacology:
Dr Rani Khatib FESC @DrRaniKhatib
Felice Gragnano @FeliceGragnano
CV Nursing & Allied Professions:
Izabella Uchmanowicz, RN. PhD, MBA,FESC, FHFA @izaUchmanowicz
Catherine Ross @izaUchmanowicz
Maggie Simpson @m4ggiesimpson
Angela Durante @Angie_Durante89
CVD in Special Populations:
Novi Yanti Sari @slumberbell
Maggie Simpson @m4ggiesimpson
Martha Gulati @DrMarthaGulati (who also ranks world #7 for impact in Heart Failure, in @CREATION DOL Finder demo on our stand E555)
Anastasia Mihailidou @AnastasiaSMihai
Basic Science:
Daniel Johnson @danmjohnson
Luca Liberale @liberale_luca
Oren Caspi @MDCaspi
Arrhythmias & Device Therapy:
Panteleimon Pantelidis @pan_pantelidis
Monika Gawalko @GawalkoMonika
Priya Bhardwaj @priyapbk
Vera Maslova @veramasloo
Dominik Linz @Dominik_Linz
Stefan Simovic @simovicst
Yanushi Dullewe Wijeyeratne @DrYanushiDW
1
3
216
